01 1Jiangxi Synergy Pharmaceutical
01 1EMPAGLIFLOZIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-05-10
Pay. Date : 2023-08-11
DMF Number : 37622
Submission : 2022-11-02
Status : Active
Type : II
20
Jiangxi Synergy Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EMPAGLIFLOZIN, with a corresponding US DMF Number 37622.
Remarkably, this DMF maintains an Active status since its submission on November 02, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 10, 2024, and payment made on August 11, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
